Nutrition status of adults with phenylketonuria treated with pegvaliase

Background: Pegvaliase is an enzyme substitution therapy that reduces blood phenylalanine (Phe) in adults with phenylketonuria (PKU), and often allows normalization of protein intake (>= 0.8 g protein/kg). Here we examine the nutrition status of adults with PKU consuming a normal protein intake without medical food after being treated with pegvaliase for >= 1 year. Methods: A cross-sectional study evaluating nutritional intake (3-day food record and food frequency questionnaire), anthropometrics, laboratory indices of protein, micronutrient, and essential fatty acid (EFA) status, and questionnaires evaluating food neophobia and Epicurean eating pleasure. Results: Participants (n = 18, 61% female) started pegvaliase 4.9 +/- 2.1 years prior to enrollment and were aged 38.2 +/- 8.8 years with a mean BMI of 29.2 +/- 4.1 kg/m(2). Participants consumed a mean of 73.2 +/- 17.6 g protein/d (1.0 +/- 0.3 g/kg/d). Eleven participants had low blood Phe (<30 mu mol/L) with adequate protein intake and normal indices of protein status. Micronutrient and EFA concentrations were normal except for mildly low vitamin D (<30 ng/mL, n = 12). Intakes of sodium, saturated fat, and added sugars exceeded recommendations for healthy adults, though mean diet quality was comparable to a US adult reference population. Lower food neophobia scores correlated with an increased aesthetic appreciation of food. However, 53% of participants self-reported having moderate (n = 6) to high (n = 3) food neophobia. Discussion: Participants treated with pegvaliase consumed an unrestricted diet with adequate dietary protein and, overall, had normal protein, micronutrient, and fatty acid status. Despite low blood Phe, protein nutriture was not compromised. While nutritional deficiencies were not identified, diet quality was suboptimal and some participants reported food neophobia. Nutrition education remains an important component of care as patients adapt to a normal diet. (C) 2021 Elsevier Inc. All rights reserved.

Automated summary

Adults with PKU treated with pegvaliase have normal nutritional intake, protein, micronutrient, and fatty acid status when consuming a normal protein diet, but suboptimal diet quality and some individuals may experience food neophobia.